[1] 田耀辉, 姚鑫, 杨玉山, 陈步东, 蔡邵帅, 乔婕. 人脑胶质瘤组织中耐药相关基因蛋白MGMT、Topo-Ⅱ、GST-π、P-gp的表达变化及意义 [J]. 山东医药 2010.doi:10.3969/j.issn.1002-266X.2010.26.043 [2] 赵焕芬, 张咏梅, 何春年, 宋光耀, 翟金萍, ZHAO Huan-fe, ZHANG Yong-mei, HE Chun-nian, SONG Guang-yao, ZHAI Jin-ping. 肺癌组织中低氧诱导因子1α表达与肿瘤耐药关系的研究 [J]. 中华肿瘤防治杂志 2008.doi:10.3969/j.issn.1673-5269.2008.07.012 [3] 刘军, 汪永红, 王昌富. 谷胱甘肽S-转移酶-π的生物学特性及其临床应用 [J]. 国际检验医学杂志 2007.doi:10.3969/j.issn.1673-4130.2007.01.022 [4] Martinez C, Martin F, Fernandez JM, Garcia Martin E, Sastre J, Diaz Rubio M, Agundez JA, Ladero JM. Glutathione S-transferases mu1, theta1, pi1, alpha1 and mu3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. [J]. Pharmacogenomics 2006, 5(5). [5] 李之山, 张汝刚, 罗贤懋. 谷胱甘肽转移酶π在人食管鳞癌中的表达 [J]. 中华肿瘤杂志 2001, 23(01). [6] Shen H, Kanvar L, Tew K D. Importence of glutathione and associated enzymes in drugresponse [J]. Oncology Research 1997, 9(06). [7] Ban N, Takahashi Y, Takayam T. Transfection of glutathione-S-transferase(GST)-π antisense complementary DNA increase the sensitivity of a colon cancer cell line to adriamycin, cisplation, melphalan and etoposlad [J]. Cancer Research 1996, 56(15). |